Related Experiment Videos
Reducing resistance to diabetes treatment using short narrative interventions
Moshe Mishali1, Luba Sominsky, Anthony David Heymann
1Department of Psychology, University of Tel Aviv, Tel Aviv, Israel.
Family Practice
|December 25, 2009
Summary
Empathic narratives help healthcare professionals understand and reduce patient resistance to diabetes treatment. This narrative-based technique empowers individuals, improving their adherence and overall management of diabetes.
Area of Science:
- Medical Education
- Patient Adherence
- Behavioral Science
Background:
- Diabetes management requires addressing patient adherence.
- Patient resistance to treatment is a significant barrier.
- Understanding reasons for resistance is crucial for effective intervention.
Purpose of the Study:
- To present a narrative-based technique to empower patients with diabetes.
- To improve patient adherence through empathic narratives.
- To explore the effectiveness of narrative interventions in reducing treatment resistance.
Main Methods:
- A study involved 123 patients diagnosed with diabetes at Maccabi Healthcare Services.
- Four empathic narratives were created based on identified factors of treatment resistance.
- Patients evaluated narrative relevance to their reasons for resistance using a designed questionnaire.
Main Results:
- The constructed narratives effectively corresponded to core reasons for diabetes treatment resistance.
- A significant difference was found in narrative scores related to varying levels of resistance.
- Testimonial validity of the empathic narratives was supported by patient responses.
Conclusions:
- Short narrative interventions can be utilized by healthcare professionals.
- This technique serves as a tool to reduce patient reasons for treatment resistance.
- Empowering patients through narratives can enhance diabetes management.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:23Techniques of Therapeutic Communication II: Focusing, Paraphrasing, and Summarizing
Focusing involves centering a conversation on a message's critical elements or concepts. Focusing is valuable if the talk is vague or patients begin to repeat themselves. Sometimes, when patients are asked about their symptoms, they may go off-topic and try to tell their entire life story. Respectfully, the nurse should bring the conversation back into focus.
This therapeutic technique can also be used when a patient brings up pertinent information during a health-related conversation. The...
This therapeutic technique can also be used when a patient brings up pertinent information during a health-related conversation. The...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...